Companies that measure, classify, or forecast human performance face a recurring commercial problem. Their science may be valuable, but each new customer requires a new device integration, data explanation, workflow, application, and proof of value. The company is pushed toward building an entire platform even when its real advantage is the processor or analytical method.

HRT creates a different path.

A processor can become easier to discover, integrate, compare, and compose without publishing the implementation that makes it valuable.

The HRT processor role

An HRT-compatible processor receives authorized signals or references and returns documented human-runtime measurements, states, events, or forecasts.

Its Processor Profile can declare:

  • supported input modalities and devices;
  • output metrics and semantic definitions;
  • units, categories, uncertainty, and abstention behavior;
  • valid populations, tasks, and operating conditions;
  • timing, latency, and deployment modes;
  • method-version and provider provenance;
  • evidence maturity and known limitations;
  • access, comparison, retention, and learning permissions.

The profile describes how to use the capability. It does not require source code, weights, features, thresholds, training data, or internal calibration logic.

Why support an open processor slot

Distribution

An HRT-aware vertical or agent system can discover the processor by capability. The provider does not need to build the complete application for every new market.

Lower integration cost

Identity, time, task context, provenance, authorization, and outcome correlation use a common structure. The provider can focus engineering on its measurement and domain extensions.

Visible evidence

The processor can be evaluated against independent outcomes. Strong science and operational quality become visible assets rather than claims hidden inside bespoke pilots.

Composition

One processor does not need to solve every problem. An agent can combine complementary modalities, select providers by task, or use disagreement as a reason for review.

Category leadership

An early provider can help define responsible semantics, quality fields, conformance, and evaluation practices. Leadership comes from shaping the category and demonstrating value, not from forcing every participant through a proprietary integration.

Comparison is part of the offer

An open processor ecosystem must permit legitimate comparison. HRT can compare processors on:

  • interface conformance;
  • latency and availability;
  • coverage and abstention;
  • calibration;
  • robustness across devices and environments;
  • prediction of independent outcomes;
  • effect on the complete human–agent workflow.

The benchmark does not treat one provider's score as ground truth. It connects each attributed output to an independent task result, reference annotation, or intervention effect.

This makes competition more credible and less arbitrary. Providers compete on capability, evidence, reliability, domain expertise, applications, and support rather than on integration lock-in.

Protecting the implementation

The default deployment can remain provider-controlled:

authorized signals or references
    → provider-controlled processor
    → signed HRT result
    → authorized agent, vertical application, or evaluation trace

The provider chooses the disclosure tier:

  1. result access;
  2. metric access;
  3. validation access;
  4. research access;
  5. joint-development access.

HRT can supply a private Processor IP Exposure and Extractability Self-Test so the owner can measure direct leakage, functional substitution, threshold inference, telemetry exposure, and access-tier isolation before opening an interface more widely.

Why this especially matters for startups

Early human-performance companies often have strong expertise but limited reference deployments, integration capacity, and market visibility. Many are simultaneously in conversations with device companies, verticals, researchers, and platform providers without a common way to show how those relationships fit.

HRT can make progress legible:

  • compatible processor;
  • evaluated capability;
  • reference integration;
  • controlled experiment;
  • vertical pilot;
  • production deployment;
  • scientific or outcome validation.

This does not inflate conversations into adoption. It lets evidence accumulate in a reusable form.

A first processor project

  1. Select two or three outputs that are useful beyond the provider's current application.
  2. Define their semantics, quality representation, validity, and access tier.
  3. Keep raw data and proprietary processing inside the provider boundary.
  4. Build one HRT Processor Profile and adapter.
  5. Connect the outputs to a synthetic or approved vertical episode and outcome.
  6. Run conformance, usefulness, and IP-exposure tests.
  7. Decide whether to remain private, become a reference processor, or enter a wider pilot.

Concise case for participation

HRT gives your processor a reusable place in agent and vertical systems. You expose a controlled capability contract, not your implementation. Integrators can discover what the processor supports, invoke it through an authorized interface, connect its outputs to tasks and outcomes, and compare it fairly with alternatives. You retain your algorithms, data, extensions, products, and customer relationships. HRT supplies the shared trace, evaluation, policy, and agent-facing layer. The result is competition and composability between processors while protecting their implementations.